(VIANEWS) – The NASDAQ ended the session with TherapeuticsMD rising 5.3% to $0.71 on Tuesday, following the last session’s downward trend. NASDAQ Composite rose 0.22% to $14,746.40, after five successive sessions in a row of losses, on what was a somewhat bullish trend trading session today.
Today’s last reported volume for TherapeuticsMD is 5594570, 3.94% below its average volume of 5824560.
TherapeuticsMD’s last close was $0.80, 70.91% below its 52-week high of $2.75.
TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the present quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.71 at 17:16 EST, way below its 52-week high of $2.75 and above its 52-week low of $0.68.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way under its 50-day moving average of $0.82 and way below its 200-day moving average of $1.13.
More news about TherapeuticsMD (TXMD).